<DOC>
	<DOCNO>NCT01714635</DOCNO>
	<brief_summary>The purpose clinical trial evaluate safety effectiveness TECNIS Multifocal 1-Piece Intraocular Lens ( IOLs ) , Models ZKB00 ZLB00 provide statistically good distance-corrected near visual acuity compare monofocal control lens . Complication adverse event rate associate Multifocal IOL within ISO SPE rate posterior chamber IOLs .</brief_summary>
	<brief_title>Clinical Investigation Expanded Designs Multifocal IOL</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<criteria>Minimum 18 year age Bilateral cataracts phacoemulsification extraction posterior IOL implantation plan eye Preoperative bestcorrected distance visual acuity ( BCDVA ) 20/40 worse ( Snellen ) without glare source Potential postoperative bestcorrected visual acuity 20/25 well Preoperative corneal astigmatism 1.0 D less normal corneal topography irregular corneal astigmatism Clear intraocular medium , cataract Availability , willingness sufficient cognitive awareness comply examination procedure Signed informed consent HIPAA authorization equivalent documentation necessary comply applicable privacy law pertain medical treatment govern country Ability understand respond questionnaire verbally administer English Requiring intraocular lens power outside available range +16.0 +28.0 D Pupil abnormality ( nonreactive , fix pupil , abnormally shape pupil ) Recent ocular trauma ocular surgery resolved/stable may affect visual outcome Prior refractive ( LASIK , LASEK , RK , PRK , etc . ) intraocular surgery Corneal abnormalities stromal , epithelial endothelial dystrophy predict cause visual acuity loss level 20/30 bad study Inability achieve keratometric stability contact lens wearer Subjects diagnose degenerative visual disorder ( e.g. , macular degeneration retinal disorder ) predict cause visual acuity loss level 20/30 bad study Subjects condition associate increase risk zonular rupture , include capsular zonular abnormality may lead IOL decentration , include pseudoexfoliation , trauma , posterior capsule defect Use systemic ocular medication may affect vision Prior , current , anticipated use course 12month study tamsulosin silodosin ( e.g. , Flomax® , Flomaxtra® , Rapaflo® ) likely , opinion investigator , cause poor dilation lack adequate iris structure perform standard cataract surgery Inability focus , fixate maintain binocular vision prolong period time ( e.g. , due strabismus , nystagmus , etc . ) Poorlycontrolled diabetes Acute , chronic , uncontrolled systemic ocular disease illness , opinion investigator , would increase operative risk confound outcome study ( e.g. , immunocompromised , connective tissue disease , suspect glaucoma , glaucomatous change fundus visual field , ocular inflammation , etc. ) . Note : ocular hypertension without glaucomatous change acceptable . Known ocular disease pathology may affect visual acuity may expect require retinal laser treatment surgical intervention course study ( macular degeneration , cystoid macular edema , diabetic retinopathy , etc . ) Patient pregnant , plan become pregnant , lactate another condition associate fluctuation hormone could lead refractive change Concurrent participation participation within 30 day prior preoperative visit clinical trial Desire monovision correction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>cataract</keyword>
	<keyword>IOL</keyword>
	<keyword>intraocular lens</keyword>
</DOC>